Theranos Investor Conference Presentation Deck slide image

Theranos Investor Conference Presentation Deck

Immunochemistry: HSV-2 IgG Precision Results Show Acceptable %CV Analyte HSV-2 Index Value 0.75 (L) 1.06 (H) Repeatability CV Within-laboratory CV Reproducibility CV (Within-day) (Within-miniLab) (Across 3 miniLabs) 7.6% 7.6% 7.7% 7.3% 7.5% 7.7% (L): low titre sample; (H): high titre sample Other industry standard assays approved by FDA: K120625, K090409, K081687 This technology has not been cleared or approved by the FDA and is not for sale in the United States. theranos 34
View entire presentation